Research status and strategies of preventing mother-to-child transmission of hepatitis B.
10.3760/cma.j.issn.0253-9624.2016.02.019
- VernacularTitle:乙型肝炎病毒母婴阻断研究进展及对策
- Author:
Tao JIA
1
;
Rui WANG
Author Information
1. China National Biotec Group Company Limited, Beijing 100012, China.
- Publication Type:Journal Article
- MeSH:
Female;
Hepatitis B;
prevention & control;
transmission;
Hepatitis B Surface Antigens;
blood;
Hepatitis B Vaccines;
therapeutic use;
Humans;
Immunoglobulins;
therapeutic use;
Infant;
Infectious Disease Transmission, Vertical;
prevention & control;
Mothers;
Pregnancy;
Pregnancy Complications, Infectious;
virology;
Prevalence;
Vaccination
- From:
Chinese Journal of Preventive Medicine
2016;50(2):197-200
- CountryChina
- Language:Chinese
-
Abstract:
Mother-to-child transmission (MTCT) is the main way to transmit hepatitis B virus (HBV), and it is also the biggest contributor to high prevalence of hepatitis B in high endemic areas. Therefore, preventing MTCT may result in the decline of HBV positive ratio foundationally. Hepatitis B vaccination is currently recognized as the most economic, effective and safe measure to prevent MTCT. The key strategies in the future to prevent MTCT should be to enhance the screening of hepatitis B surface antigen, to provide the infants born to surface antigen positive mother with hepatitis B vaccine combine with hepatitis B immunoglobulin(HBIG), and to monitor the effect of the intervention.
